Icrucumab (Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) 是一种人源化的抗VEGFR-1IgG1 单克隆抗体。Icrucumab 具有用于晚期实体瘤研究的潜力。
| 生物活性 | Icrucumab (Anti-VEGFR1/FLT1 Reference Antibody; IMC-18F1) is a humanizedAnti-VEGFR-1IgG1monoclonal antibody. Icrucumab has the potential for the research of advanced solid tumors[1]. |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com